Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Mylan's Lantus Rival Faces Fresh Attack
Sanofi Tries To Stop Biosimilar Via Supreme Court PTAB Review
Mar 02 2020
•
By
Brenda Sandburg
Sanofi Says Unconstitutional Status Of PTAB Judges Warrants Appeal of Lantus Ruling • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin